An underlying carcinoma is an important differential diagnosis in peri
pheral neuropathy. While direct compression and infiltration of spinal
roots or peripheral or cranial nerve trunks or branches can be identi
fied easily when they occur in association with established malignancy
, their diagnosis when they are presenting features may be difficult.
In paraneoplastic sensory neuronopathy autoantibodies to neuronal anti
gens have become useful diagnostic markers for an underlying carcinoma
, especially anti-Hu antibodies. Strong circumstantial evidence sugges
ts that these antibodies form part of an autoimmune response which is
responsible for the pathogenesis of some of these syndromes. Neuropath
y appearing during the course of treatment of carcinoma may be due to
radiation-induced damage or the neurotoxic effects of some chemotherap
eutic agents, Neurotrophic factors are being investigated as a strateg
y for reducing the neurotoxic effects of these agents.